Full Name
YAP CHUN WEI
(not current staff)
Variants
Yap, C.W.
Wei, Y.C.
Chun, W.Y.
Yap, C.-W.
 
Main Affiliation
 
 
Email
phayapc@nus.edu.sg
 
Other emails
 

Publications

Results 1-20 of 64 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)
11-May-20123D-QSAR Study on dihydro-1,3,5-triazines and their spiro derivatives as DHFR inhibitors by comparative molecular field analysis (CoMFA)Ma, X. ; Xiang, G.; Yap, C.-W. ; Chui, W.-K. 
21-Aug-2012A clinical decision support tool to predict survival in cancer patients beyond 120 days after palliative chemotherapyNg, T.; Chew, L. ; Yap, C.W. 
37-Aug-2011A fully automated iterative moving averaging (AIMA) technique for baseline correctionPrakash, B.D.; Wei, Y.C. 
4Jun-2008A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment systemKoh, Y. ; Yap, C.W. ; Li, S.C. 
521-May-2013An automated Pearson's correlation change classification (APC3) approach for GC/MS metabonomic data using total ion chromatograms (TICs)Prakash, B.D.; Esuvaranathan, K.; Ho, P.C. ; Pasikanti, K.K.; Yong Chan, E.C. ; Yap, C.W. 
6Aug-2012An investigation of the bioactivation potential and metabolism profile of zebrafish versus humanChng, H.T.; Ho, H.K. ; Yap, C.W. ; Lam, S.H. ; Chan, E.C.Y. 
71-Sep-2011Anticancer activity of thymoquinone in breast cancer cells: Possible involvement of PPAR-γ pathwayWoo, C.C.; Loo, S.Y.; Gee, V.; Yap, C.W. ; Sethi, G.; Kumar, A.P. ; Benny Tan, K.H.
8Aug-2006Application of support vector machines to in silico prediction of cytochrome P450 enzyme substrates and inhibitorsYap, C.W. ; Xue, Y.; Li, Z.R.; Chen, Y.Z. 
92012Automated systems to identify relevant documents in product risk managementWee, X.T.; Koh, Y.; Yap, C.W. 
10Aug-2006Classification of a diverse set of Tetrahymena pyriformis toxicity chemical compounds from molecular descriptors by statistical learning methodsXue, Y. ; Li, H. ; Ung, C.Y. ; Yap, C.W. ; Chen, Y.Z. 
111-Aug-2012Clinical and demographic predictors for vitamin D deficiency in multiethnic Asian patients with chronic kidney diseaseLoh, ZY; Yap, CW ; Vathsala, A ; How, P 
1224-Dec-2010Comparative evaluation of software for retention time alignment of gas chromatography/time-of-flight mass spectrometry-based metabonomic dataKoh, Y.; Pasikanti, K.K.; Yap, C.W. ; Chan, E.C.Y. 
13Jan-2007Computer prediction of cardiovascular and hematological agents by statistical learning methodsChen, X. ; Li, H. ; Yap, C.W. ; Ung, C.Y. ; Jiang, L. ; Cao, Z.W.; Li, Y.X.; Chen, Y.Z. 
14Feb-2010Consensus model for identification of novel PI3K inhibitors in large chemical libraryLiew, C.Y.; Ma, X.H. ; Yap, C.W. 
15Aug-2012Consensus QSAR model for identifying novel H5N1 inhibitorsSharma, N.; Yap, C.W. 
169-Mar-2012Current Modeling Methods Used in QSAR/QSPRYee, L.C.; Wei, Y.C. 
177-Dec-2006Current QSAR Techniques for ToxicologyChen, Y.Z. ; Yap, C.W. ; Li, H. 
18Mar-2013Determination of the potential of drug candidates to cause severe skin disorders using computational modelingHe, Y.; Chong, F.H.T.; Lim, J.; Lee, R.J.T.; Yap, C.W. 
192012Determination of Torsade-causing potential of drug candidates using one-class classification and ensemble modelling approachesHe, Y.; Lim, S.W.Y.; Yap, C.W. 
20Nov-2010Development of a combined system for identification and classification of adverse drug reactions: Alerts based on ADR causality and severity (ABACUS)Koh, Y. ; Yap, C.W. ; Li, S.-C.